GlassScriptPhysician profile
Alan M Spiegel
NPI 1770580326
$10,452.90
in general payments reported to CMS, 2019-2025
41 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,599 · 2020: $1,092 · 2021: $483 · 2022: $458 · 2023: $2,240 · 2024: $2,023 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,163 · Consulting Fee: $337 · Travel and Lodging: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,163.32 |
| Consulting Fee | $337.00 |
| Travel and Lodging | $320.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,555.43 | 2019-2025 | Watchman Access System, Watchman Flx, Opticross |
| Novartis Pharmaceuticals Corporation | $1,452.89 | 2019-2025 | |
| Ge Healthcare | $908.00 | 2020-2023 | |
| Edwards Lifesciences Corporation | $797.99 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $512.22 | 2019-2025 | Mitraclip, Cardiomems, Coroflow |
| Pfizer INC. | $497.68 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $438.66 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $410.76 | 2019-2024 | Xarelto |
| Amgen INC. | $358.67 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $291.07 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $284.40 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $231.92 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.82 | 2019-2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $167.43 | 2025 | |
| Kestra Medical Technology Services, INC. | $165.68 | 2024-2025 | Assure Wcd |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.